These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 15280393)
21. Binding of elongin A or a von Hippel-Lindau peptide stabilizes the structure of yeast elongin C. Botuyan MV; Koth CM; Mer G; Chakrabartty A; Conaway JW; Conaway RC; Edwards AM; Arrowsmith CH; Chazin WJ Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9033-8. PubMed ID: 10430890 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface. Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582 [TBL] [Abstract][Full Text] [Related]
23. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. Stebbins CE; Kaelin WG; Pavletich NP Science; 1999 Apr; 284(5413):455-61. PubMed ID: 10205047 [TBL] [Abstract][Full Text] [Related]
24. Solution structure and dynamics of yeast elongin C in complex with a von Hippel-Lindau peptide. Botuyan MV; Mer G; Yi GS; Koth CM; Case DA; Edwards AM; Chazin WJ; Arrowsmith CH J Mol Biol; 2001 Sep; 312(1):177-86. PubMed ID: 11545595 [TBL] [Abstract][Full Text] [Related]
25. Structure-Guided Design of Peptides as Tools to Probe the Protein-Protein Interaction between Cullin-2 and Elongin BC Substrate Adaptor in Cullin RING E3 Ubiquitin Ligases. Cardote TAF; Ciulli A ChemMedChem; 2017 Sep; 12(18):1491-1496. PubMed ID: 28776949 [TBL] [Abstract][Full Text] [Related]
26. Structure of a glomulin-RBX1-CUL1 complex: inhibition of a RING E3 ligase through masking of its E2-binding surface. Duda DM; Olszewski JL; Tron AE; Hammel M; Lambert LJ; Waddell MB; Mittag T; DeCaprio JA; Schulman BA Mol Cell; 2012 Aug; 47(3):371-82. PubMed ID: 22748924 [TBL] [Abstract][Full Text] [Related]
27. Selective recruitment of an E2~ubiquitin complex by an E3 ubiquitin ligase. Spratt DE; Wu K; Kovacev J; Pan ZQ; Shaw GS J Biol Chem; 2012 May; 287(21):17374-17385. PubMed ID: 22433864 [TBL] [Abstract][Full Text] [Related]
28. Insights into Cullin-RING E3 ubiquitin ligase recruitment: structure of the VHL-EloBC-Cul2 complex. Nguyen HC; Yang H; Fribourgh JL; Wolfe LS; Xiong Y Structure; 2015 Mar; 23(3):441-449. PubMed ID: 25661653 [TBL] [Abstract][Full Text] [Related]
29. HIF-1alpha and EPAS ubiquitination mediated by the VHL tumour suppressor involves flexibility in the ubiquitination mechanism, similar to other RING E3 ligases. Paltoglou S; Roberts BJ Oncogene; 2007 Jan; 26(4):604-9. PubMed ID: 16862177 [TBL] [Abstract][Full Text] [Related]
30. Phosphorylation- and Skp1-independent in vitro ubiquitination of E2F1 by multiple ROC-cullin ligases. Ohta T; Xiong Y Cancer Res; 2001 Feb; 61(4):1347-53. PubMed ID: 11245432 [TBL] [Abstract][Full Text] [Related]
31. Structural basis of intersubunit recognition in elongin BC-cullin 5-SOCS box ubiquitin-protein ligase complexes. Kim YK; Kwak MJ; Ku B; Suh HY; Joo K; Lee J; Jung JU; Oh BH Acta Crystallogr D Biol Crystallogr; 2013 Aug; 69(Pt 8):1587-97. PubMed ID: 23897481 [TBL] [Abstract][Full Text] [Related]
32. Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast. Patton EE; Willems AR; Sa D; Kuras L; Thomas D; Craig KL; Tyers M Genes Dev; 1998 Mar; 12(5):692-705. PubMed ID: 9499404 [TBL] [Abstract][Full Text] [Related]
33. The F-box protein Skp2 is a ubiquitylation target of a Cul1-based core ubiquitin ligase complex: evidence for a role of Cul1 in the suppression of Skp2 expression in quiescent fibroblasts. Wirbelauer C; Sutterlüty H; Blondel M; Gstaiger M; Peter M; Reymond F; Krek W EMBO J; 2000 Oct; 19(20):5362-75. PubMed ID: 11032804 [TBL] [Abstract][Full Text] [Related]
34. Role of SOCS and VHL Proteins in Neuronal Differentiation and Development. Kanno H; Matsumoto S; Yoshizumi T; Nakahara K; Kubo A; Murata H; Shuin T; U HS Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835292 [TBL] [Abstract][Full Text] [Related]
35. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2. Lonergan KM; Iliopoulos O; Ohh M; Kamura T; Conaway RC; Conaway JW; Kaelin WG Mol Cell Biol; 1998 Feb; 18(2):732-41. PubMed ID: 9447969 [TBL] [Abstract][Full Text] [Related]
36. Inactivation of VHL by tumorigenic mutations that disrupt dynamic coupling of the pVHL.hypoxia-inducible transcription factor-1alpha complex. Miller F; Kentsis A; Osman R; Pan ZQ J Biol Chem; 2005 Mar; 280(9):7985-96. PubMed ID: 15611064 [TBL] [Abstract][Full Text] [Related]
37. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products. Schoenfeld AR; Davidowitz EJ; Burk RD Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8507-12. PubMed ID: 10900011 [TBL] [Abstract][Full Text] [Related]
38. Rapid E2-E3 assembly and disassembly enable processive ubiquitylation of cullin-RING ubiquitin ligase substrates. Kleiger G; Saha A; Lewis S; Kuhlman B; Deshaies RJ Cell; 2009 Nov; 139(5):957-68. PubMed ID: 19945379 [TBL] [Abstract][Full Text] [Related]